Laffer Tengler Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
3,926
-227
| -5% | -$101K | 0.31% | 85 |
|
|
2025
Q1 | $2.01M | Buy |
4,153
+19
| +0.5% | +$9.21K | 0.43% | 73 |
|
|
2024
Q4 | $1.66M | Buy |
4,134
+1,260
| +44% | +$507K | 0.33% | 80 |
|
|
2024
Q3 | $1.34M | Buy |
2,874
+82
| +3% | +$38.1K | 0.27% | 89 |
|
|
2024
Q2 | $1.31M | Buy |
2,792
+539
| +24% | +$253K | 0.28% | 91 |
|
|
2024
Q1 | $942K | Buy |
2,253
+2,246
| +32,086% | +$939K | 0.24% | 90 |
|
|
2023
Q4 | $2.85K | Buy |
+7
| New | +$2.85K | ﹤0.01% | 363 |
|
|
2022
Q2 | – | Sell |
-10
| Closed | -$2.61K | – | 430 |
|
|
2022
Q1 | $2.61K | Hold |
10
| – | – | ﹤0.01% | 357 |
|
|
2021
Q4 | $2.2K | Hold |
10
| – | – | ﹤0.01% | 338 |
|
|
2021
Q3 | $1.81K | Buy |
+10
| New | +$1.81K | ﹤0.01% | 439 |
|